The Sackler family and Purdue Pharma, the maker of the addictive painkiller oxycontin, have reached a $7.4 billion settlement ...

The deal comes after the Supreme Court blocked a controversial bankruptcy plan for Purdue that shielded Sackler family members from future lawsuits.

Purdue Pharma and the Sackler families agreed Thursday to increase their financial contribution to $7.4 billion to resolve mass opioid litigation.

Several states have reached a $7.4 billion settlement with the Sackler family and their pharmaceutical company Purdue over the opioid crisis.

Purdue Pharma and the members of the Sackler family ... to resolve thousands of lawsuits over their alleged role in the opioid crisis, state attorneys general announced Thursday.

This story incorporates reporting fromBoston.com, Philadelphia Inquirer, The Boston Globe, pharmaphorum, Hartford Courant, BioSpace and Yahoo.

The deal, agreed to by Purdue Pharma, the Sackler family members who own the company and lawyers representing state and local ...

Billings, compares the state’s purchase of overdose reversal drugs like Narcan from companies that have contributed to the ...

The recent settlement that would see Purdue Pharma and its owners, the Sackler family, pay $7.4 billion to resolve lawsuits filed by state and local governments across the country is ...

Last week’s settlement that would see Purdue Pharma and its owners, the Sackler family, pay $7.4 billion to resolve lawsuits filed by state and local governments across the country is ...

Purdue Pharma and its owners, the Sackler family, reached a settlement of up to $7.4 billion for its role in the opioid crisis, less than a year after the Supreme Court tossed out a proposed $6 ...

Last week’s settlement that would see Purdue Pharma and its owners, the Sackler family, pay $7.4 billion to resolve lawsuits filed by state and local governments across the country is ...